Two constructed antibody-derived delivery vehicles for targeting oligodeoxynucleotides to prostate tumors expressing prostate specific antigen. [electronic resource]
- Drug delivery
- 161-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't